184 related articles for article (PubMed ID: 17347483)
21. Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS).
Bigalke B; Stellos K; Weig HJ; Geisler T; Seizer P; Kremmer E; Pötz O; Joos T; May AE; Lindemann S; Gawaz M
Basic Res Cardiol; 2009 May; 104(3):352-7. PubMed ID: 19190951
[TBL] [Abstract][Full Text] [Related]
22. Chronic treatment with losartan results in sufficient serum levels of the metabolite EXP3179 for PPARgamma activation.
Kappert K; Tsuprykov O; Kaufmann J; Fritzsche J; Ott I; Goebel M; Bähr IN; Hässle PL; Gust R; Fleck E; Unger T; Stawowy P; Kintscher U
Hypertension; 2009 Oct; 54(4):738-43. PubMed ID: 19687349
[TBL] [Abstract][Full Text] [Related]
23. Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension.
Fortuño A; Bidegain J; Robador PA; Hermida J; López-Sagaseta J; Beloqui O; Díez J; Zalba G
Hypertension; 2009 Oct; 54(4):744-50. PubMed ID: 19687351
[TBL] [Abstract][Full Text] [Related]
24. Regulation of peroxisome proliferator-activated receptor gamma activity by losartan metabolites.
Schupp M; Lee LD; Frost N; Umbreen S; Schmidt B; Unger T; Kintscher U
Hypertension; 2006 Mar; 47(3):586-9. PubMed ID: 16365190
[TBL] [Abstract][Full Text] [Related]
25. Collagen-type specificity of glycoprotein VI as a determinant of platelet adhesion.
Jung SM; Takemura Y; Imamura Y; Hayashi T; Adachi E; Moroi M
Platelets; 2008 Feb; 19(1):32-42. PubMed ID: 18231936
[TBL] [Abstract][Full Text] [Related]
26. Local delivery of soluble platelet collagen receptor glycoprotein VI inhibits thrombus formation in vivo.
Bültmann A; Herdeg C; Li Z; Münch G; Baumgartner C; Langer H; Kremmer E; Geisler T; May A; Ungerer M; Gawaz M
Thromb Haemost; 2006 May; 95(5):763-6. PubMed ID: 16676064
[TBL] [Abstract][Full Text] [Related]
27. Highly potent anti-human GPVI monoclonal antibodies derived from GPVI knockout mouse immunization.
Matsumoto Y; Takizawa H; Gong X; Le S; Lockyer S; Okuyama K; Tanaka M; Yoshitake M; Tandon NN; Kambayashi J
Thromb Res; 2007; 119(3):319-29. PubMed ID: 16566959
[TBL] [Abstract][Full Text] [Related]
28. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377
[TBL] [Abstract][Full Text] [Related]
29. Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia.
Messadi-Laribi E; Griol-Charhbili V; Pizard A; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
J Pharmacol Exp Ther; 2007 Oct; 323(1):210-6. PubMed ID: 17636004
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic and therapeutic potentials of platelet glycoprotein VI.
Bigalke B; Krämer BF; Seizer P; Fateh-Moghadam S; Gawaz M; Lindemann S
Semin Thromb Hemost; 2010 Mar; 36(2):203-11. PubMed ID: 20414836
[TBL] [Abstract][Full Text] [Related]
31. Ex vivo evaluation of anti-GPVI antibody in cynomolgus monkeys: dissociation between anti-platelet aggregatory effect and bleeding time.
Matsumoto Y; Takizawa H; Nakama K; Gong X; Yamada Y; Tandon NN; Kambayashi J
Thromb Haemost; 2006 Aug; 96(2):167-75. PubMed ID: 16894460
[TBL] [Abstract][Full Text] [Related]
32. The glycoprotein VI-phospholipase Cgamma2 signaling pathway controls thrombus formation induced by collagen and tissue factor in vitro and in vivo.
Munnix IC; Strehl A; Kuijpers MJ; Auger JM; van der Meijden PE; van Zandvoort MA; oude Egbrink MG; Nieswandt B; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2673-8. PubMed ID: 16254207
[TBL] [Abstract][Full Text] [Related]
33. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a novel and potent collagen antagonist, caffeic acid phenethyl ester, in human platelets: in vitro and in vivo studies.
Hsiao G; Lee JJ; Lin KH; Shen CH; Fong TH; Chou DS; Sheu JR
Cardiovasc Res; 2007 Sep; 75(4):782-92. PubMed ID: 17560560
[TBL] [Abstract][Full Text] [Related]
35. Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome.
Bigalke B; Lindemann S; Ehlers R; Seizer P; Daub K; Langer H; Schonberger T; Kremmer E; Siegel-Axel D; May AE; Gawaz M
Eur Heart J; 2006 Sep; 27(18):2165-9. PubMed ID: 16923742
[TBL] [Abstract][Full Text] [Related]
36. Anti GPVI human antibodies neutralizing collagen-induced platelet aggregation isolated from a combinatorial phage display library.
Qian MD; Villeval JL; Xiong X; Jandrot-Perrus M; Nagashima K; Tonra J; McDonald K; Goodearl A; Gill D
Hum Antibodies; 2002; 11(3):97-105. PubMed ID: 12454370
[TBL] [Abstract][Full Text] [Related]
37. Dimeric Glycoprotein VI Binds to Collagen but Not to Fibrin.
Ebrahim M; Jamasbi J; Adler K; Megens RTA; M'Bengue Y; Blanchet X; Uhland K; Ungerer M; Brandl R; Weber C; Elia N; Lorenz R; Münch G; Siess W
Thromb Haemost; 2018 Feb; 118(2):351-361. PubMed ID: 29378359
[TBL] [Abstract][Full Text] [Related]
38. Anti-GPVI Fab SAR264565 effectively blocks GPVI function in ex vivo human platelets under arterial shear in a perfusion chamber.
Florian P; Wonerow P; Harder S; Kuczka K; Dubar M; Graff J
Eur J Clin Pharmacol; 2017 Aug; 73(8):949-956. PubMed ID: 28523478
[TBL] [Abstract][Full Text] [Related]
39. GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism.
Lockyer S; Okuyama K; Begum S; Le S; Sun B; Watanabe T; Matsumoto Y; Yoshitake M; Kambayashi J; Tandon NN
Thromb Res; 2006; 118(3):371-80. PubMed ID: 16139873
[TBL] [Abstract][Full Text] [Related]
40. The modified Je-Ho-Tang, Korean herbal medicine, inhibits whole-blood aggregation and platelet adhesion to collagen under flow.
Jeon WK; Kim YE; Park SO; Kwon DY; Ahn SW; Lee JH; Ji MS; Ko BS
Thromb Res; 2008; 122(6):804-9. PubMed ID: 18448152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
